SCHEMBL6132475

SCHEMBL6132475

c1cc(N2CCNCC2)ccc1C1CNCCC12CCCC2

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ADRB1 P08588 7/20 0.42
SIGMAR1 Q99720 5/20 0.42
HTR3E A5X5Y0 4/20 0.42
HTR3B O95264 4/20 0.42
HTR3A P46098 4/20 0.42
HTR3D Q70Z44 4/20 0.42
HTR3C Q8WXA8 4/20 0.42
ADRB2 P07550 1/20 0.39
NCF1 P14598 1/20 0.39
PLD1 Q13393 1/20 0.39
USP2 O75604 3/20 0.39
CYP2D6 P10635 2/20 0.39
LTA4H P09960 4/20 0.38
ALDH1A1 P00352 3/20 0.38
KDM4E B2RXH2 1/20 0.38
LMNA P02545 1/20 0.38
SIRT6 Q8N6T7 1/20 0.38
TSHR P16473 2/20 0.36
HSD17B10 Q99714 1/20 0.36
HTR6 P50406 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6132472 0.75 ADRB1 (0.43) ADRB1SIGMAR1HTR3EHTR3BHTR3A
SCHEMBL17135722 0.73 OPRM1 (0.44) SIGMAR1ALDH1A1KDM4ETSHRHSD17B10
SCHEMBL10161191 0.72 HTR3A (0.56) ADRB1SIGMAR1HTR3EHTR3BHTR3A
SCHEMBL2303349 0.70 CYP2D6 (0.38) ADRB2NCF1PLD1CYP2D6ALDH1A1
SCHEMBL5570604 0.70 ADRB1 (0.77) ADRB1SIGMAR1HTR3EHTR3BHTR3A
SCHEMBL15568523 0.70 TAAR1 (0.41) SIGMAR1ALDH1A1KDM4EHSD17B10CYP3A4
SCHEMBL38661103 0.68 ADRB1 (0.53) ADRB1SIGMAR1HTR3EHTR3BHTR3A
SCHEMBL17276864 0.68 ADRB1 (0.68) ADRB1SIGMAR1HTR3EHTR3BHTR3A
SCHEMBL4252026 0.68 ADRB1 (0.57) ADRB1SIGMAR1HTR3EHTR3BHTR3A
SCHEMBL6618068 0.67 ADRB1 (0.52) ADRB1SIGMAR1HTR3EHTR3BHTR3A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6884868-B1 Cyclic hexapeptides having antibiotic activity FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 2005-04-26 US disclosed